Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy. (Q53594442)

16 May 2018

title

Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy. (English)

1 reference

16 May 2018

author name string

Pan-Pan Hao

1

1 reference

16 May 2018

Jian-Min Yang

2

1 reference

16 May 2018

Ming-Xiang Zhang

3

1 reference

16 May 2018

Kai Zhang

4

1 reference

16 May 2018

Yu-Guo Chen

5

1 reference

16 May 2018

Cheng Zhang

6

1 reference

16 May 2018

Yun Zhang

7

1 reference

16 May 2018

publication date

27 February 2015

1 reference

16 May 2018

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

16 May 2018

volume

308

1 reference

16 May 2018

issue

9

1 reference

16 May 2018

page(s)

H1007-19

1 reference

16 May 2018

B-type natriuretic peptide, a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Role of changes in cardiac metabolism in development of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

The role of secondary heart field in cardiac development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Estimating pulmonary artery pressures by echocardiography in patients with emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

ACE2 improves right ventricular function in a pressure overload model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Evidence of left ventricular dysfunction in asymptomatic elderly patients with non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Right ventricular structure is associated with the risk of heart failure and cardiovascular death: the Multi-Ethnic Study of Atherosclerosis (MESA)--right ventricle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

The outflow tract of the heart is recruited from a novel heart-forming field

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Sex, sex steroids, and diabetic cardiomyopathy: making the case for experimental focus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Non-ACE pathway-induced angiotensin II production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Development of intramolecularly quenched fluorescent peptides as substrates of angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00563.2014

10.1152/AJPHEART.00563.2014

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

25724492

1 reference

16 May 2018